Get started
Author

Zengqing Guo

Observed names: Z. Guo, Zeng-Qing Guo
OpenAlex ID: A5110015141
Rising Burden of Colon and Rectum Cancer in China: An Analysis of Trends, Gender Disparities, and Projections to 2030
2025 · Zhouwei Zhan, Bijuan Chen, et al. · Annals of Surgical Oncology · 32
Long-term trends and future projections of liver cancer burden in China from 1990 to 2030
2025 · Zhouwei Zhan, Bijuan Chen, et al. · Scientific Reports · 29
PDF
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
2015 · Yuhong Li, Miaozhen Qiu, et al. · Oncotarget · 22
PDF
Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021
2024 · Zhouwei Zhan, Xiamei Chen, et al. · World Journal of Surgical Oncology · 17
PDF
First-line osemitamab (TST001) plus nivolumab and CAPOX for advanced G/GEJ cancer (TranStar102): Updated results of cohort G from a phase I/IIa study.
2025 · Jifang Gong, Dan Liu, et al. · Journal of Clinical Oncology · 11
Efficacy and safety of XNW27011, a Claudin 18.2 targeting antibody drug conjugate with topoisomerase 1 inhibitor payload, in patients with Claudin 18.2 positive gastric/gastroesophageal junction cancer: Results from ongoing phase I/II study.
2025 · Jinming Yu, Yuping Sun, et al. · Journal of Clinical Oncology · 10
PDF
Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study
2025 · Liangyu Yin, Na Li, et al. · American Journal of Clinical Nutrition · 9
Diagnostic Criteria for Cancer‐Associated Cachexia: Insights from a Multicentre Cohort Study
2025 · Zhenyu Huo, Feifei Chong, et al. · Journal of Cachexia Sarcopenia and Muscle · 8
PDF
Rising burden of pancreatic cancer in China: Trends, drivers, and future projections
2025 · Zhouwei Zhan, Xiuhui Zheng, et al. · PLoS ONE · 7
PDF
First-line osemitamab (TST001) plus nivolumab and capox for advanced g/GEJ cancer (TranStar102): Results of cohort G from a phase I/IIa study.
2024 · Xiaotian Zhang, Zengqing Guo, et al. · Journal of Clinical Oncology · 7
Long-term trends in the burden of cancer attributable to high body mass index in China from 1990 to 2021
2025 · Zhouwei Zhan, Yi Zeng, et al. · Frontiers in Nutrition · 5
DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC
2025 · Lizhu Chen, Jing Lin, et al. · Journal of Inflammation Research · 5
ASO Author Reflections: Addressing the Rising Burden of Colon and Rectum Cancer in China: Gender Disparities, Trends, and Projections
2025 · Zhouwei Zhan, Bijuan Chen, et al. · Annals of Surgical Oncology · 3
Burden, trends, and projections of nutritional deficiencies in China from 1990 to 2030
2025 · Bijuan Chen, Huanhuan Yang, et al. · Frontiers in Nutrition · 2
PDF
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
2025 · Linna Gao, Tian Yao, et al. · BMC Cancer · 2
PDF
Burden of colorectal cancer attributable to dietary risks in China from 1990 to 2021: findings from the Global Burden of Disease Study 2021
2026 · Bijuan Chen, Hanchen Zheng, et al. · Frontiers in Nutrition · 1
299P First-line osemitamab plus nivolumab and CAPOX for advanced G/GEJ cancer (TranStar102) – Updated efficacy analysis of cohort G by CLDN18.2 and PD-L1 expression from a phase I/II study
2025 · D. Liu, J. Gong, et al. · Annals of Oncology · 1
Trends and burden of colon and rectum cancer attributable to low physical activity in China: a comprehensive analysis from 1990 to 2021
2026 · Zhouwei Zhan, Bijuan Chen, et al. · Cancer Causes & Control
Age-dependent prognostic value of biological age for metastasis and survival in gastrointestinal cancer
2026 · Jingxian Zheng, Chunhua Song, et al. · Scientific Reports
PDF
The investigation of comorbidity among cancer patients in China
2026 · Chunhua Song, Chuying Zhang, et al. · Scientia Sinica Vitae
Impact of high sodium intake on stomach cancer burden in China: A comprehensive analysis from 1990 to 2021
2026 · Zhouwei Zhan, Yi Zeng, et al. · PLoS ONE
PDF
Burden and trends of cancer attributable to occupational asbestos exposure in China from 1990 to 2021
2026 · Bijuan Chen, Xiuhui Zheng, et al. · Frontiers in Public Health
PDF
Awareness and usage of a dietary guide by cancer patients and clinicians: a national survey study
2025 · Xiang-Ting Dai, Xi Zhang, et al. · Supportive Care in Cancer
Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial
2013 · Ting Deng, Nong Xu, et al. · Journal of Chemotherapy
Works count: 24
Citation count: 171
H-index: 8
I10-index: 6
Year
Topic
Type